NCT000902462 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)Postoperative Nausea and Vomiting
NCT000901552 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)Postoperative Nausea and Vomiting
Inclusion Criteria:
* Patient is at least 18 years of age.
* Patient is scheduled to undergo open abdominal surgery requiring overnight hospital stay (24-hour hospital stay after end of surgery).
* Patient is scheduled to receive general anesthesia.
* Patient is scheduled to receive postoperative o...
Frequently asked questions about MK0869, aprepitant
What is MK0869 (aprepitant) used for?
MK0869, also known as aprepitant, is an investigational small molecule being studied for the treatment of nausea, postoperative nausea and vomiting, and major depressive disorder. It is in Phase 3 clinical development for these indications.
Who makes MK0869 (aprepitant)?
MK0869 (aprepitant) is being developed by Merck & Company, Inc., which trades under the ticker symbol MRK. The company is conducting Phase 3 clinical trials to evaluate the drug for major depressive disorder and other conditions.
What phase is MK0869 (aprepitant) in?
MK0869 (aprepitant) is in Phase 3 clinical development. It is an investigational drug and has not been approved by regulatory authorities. All four completed trials were Phase 3 studies, and the drug is not currently in active trials.
What clinical trials is MK0869 (aprepitant) in?
MK0869 (aprepitant) has completed four Phase 3 clinical trials, including NCT00034944, NCT00035009, NCT00035295, and NCT00042029. These trials enrolled a total of 1,871 participants with major depressive disorder. All trials were randomized, double-blind, and uncontrolled.
Is MK0869 the same as aprepitant?
Yes, MK0869 is the same as aprepitant. The drug is referred to by both names in clinical trial records. It is being investigated for nausea, postoperative nausea and vomiting, and major depressive disorder.